| 1 |
28377426 | Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease. | 2017 Jul |
1 |
| 2 |
26401073 | Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. | 2015 Sep 21 |
2 |
| 3 |
19130519 | A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells. | 2009 |
2 |
| 4 |
16478472 | The enzyme-binding region of human GM2-activator protein. | 2006 Mar |
2 |
| 5 |
15483268 | Sequencing, expression, and enzymatic characterization of beta-hexosaminidase in rabbit lacrimal gland and primary cultured acinar cells. | 2005 Mar |
1 |
| 6 |
12662933 | Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. | 2003 Apr 11 |
2 |
| 7 |
9694901 | A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. | 1998 Aug 14 |
1 |
| 8 |
8900233 | Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant. | 1996 Nov |
1 |
| 9 |
1386984 | Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity. | 1992 Jul |
2 |
| 10 |
1834320 | Biochemistry and genetics of Tay-Sachs disease. | 1991 Aug |
1 |
| 11 |
7376831 | Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilization. | 1980 |
1 |